Document is current
Any future updates will be listed below
-
Authors
Zhang, Bin
Nguyen, Le Xuan Truong
Zhao, Dandan
Frankhouser, David E.
Wang, Huafeng
Hoang, Dinh Hoa
Qiao, Junjing
Abundis, Christina
Brehove, Matthew
Su, Yu-Lin
Feng, Yuxin
Stein, Anthony
Ghoda, Lucy
Dorrance, Adrianne
Perrotti, Danilo
Chen, Zhen
Han, Anjia
Pichiorri, Flavia
Jin, Jie
Jovanovic-Talisman, Tijana
Caligiuri, Michael A.
Kuo, Calvin J.
Yoshimura, Akihiko
Li, Ling
Rockne, Russell C.
Kortylewski, Marcin
Zheng, Yi
Carlesso, Nadia
Kuo, Ya-Huei
Marcucci, Guido https://orcid.org/0000-0002-3983-5908
-
Funding
Funding for this research was provided by:
National Cancer Institute (CA248475, CA205247)
- License Information
-
More Information
Article History
Received: 29 April 2021
Accepted: 31 July 2021
First Online: 9 August 2021
Declarations
:
: Patient sample acquisition was approved by the Institutional Review Boards (IRB) at the COHNMC, in accordance with an assurance filed with and approved by the Department of Health and Human Services and met all requirements of the Declaration of Helsinki. CML patients were consented on the IRB #18067 protocol.
: Not applicable.
: The authors declare that they have no competing interests.
